Aequus Reports Third Quarter 2021 Financial Highlights

Provided By Globe Newswire

Last update: Nov 3, 2021

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the quarter ended September 30, 2021 (“Third Quarter 2021”) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency.